首页> 外国专利> New immunosuppressive and antiinflammatory FR520 derivs. - for treating e.g. transplant resistance, rheumatoid arthritis, etc. are prepd. by acetylating 20,24,33-tri:hydroxy cpds.

New immunosuppressive and antiinflammatory FR520 derivs. - for treating e.g. transplant resistance, rheumatoid arthritis, etc. are prepd. by acetylating 20,24,33-tri:hydroxy cpds.

机译:衍生出新的免疫抑制和抗炎FR520。 -用于治疗准备移植抵抗,类风湿关节炎等。通过乙酰化20,24,33-tri:hydroxy cpds。

摘要

New 19,22-furano derivs. of FR520 of formula (I) are new: where R2 = Me, Et, n-propyl or allyl; R3 = OH or OMe; and Ac = acetyl. (I) are made by conventional acylation of the 20,24,33-trihydroxy cpds.. Reaction is e.g. in pyridine, opt. in the presence of 4-dimethylaminopyridine (A), using acetic anhydride. USE/ADVANTAGE - (I) have immunosuppressive, antiinflammatory and antiproliferative activities and so can be used to treat e.g. transplant rejection; rheumatoid arthritis; multiple sclerosis; diabetes; dermatitis; acne etc.. They can be admin. topically (at a concn. of 1-3%) or systemically at 0.15-1.5 mg/kg/day. (I) also increase the activity, effect and/or sensitivity of other chemotherapeutic agents, e.g. to reduce the normal dose of toxic antineoplastic and cytostatic agents.
机译:新的19,22-呋喃诺衍生物。式(I)的FR520中的R 5是新的:其中R 2 = Me,Et,正丙基或烯丙基; R3 = OH或OMe; Ac =乙酰基。 (I)是通过20,24,33-三羟基cpds的常规酰化反应制得的。在吡啶中,选择。在4-二甲基氨基吡啶(A)存在下,使用乙酸酐。用途/优势-(I)具有免疫抑制,抗炎和抗增殖活性,因此可用于治疗例如移植排斥类风湿关节炎;多发性硬化症;糖尿病;皮炎;痤疮等。他们可以是管理员。局部(浓度为1-3%)或全身性剂量为0.15-1.5 mg / kg /天。 (I)还增加了其他化学治疗剂,例如抗肿瘤剂的活性,作用和/或敏感性。减少有毒抗肿瘤药和细胞抑制剂的正常剂量。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号